Related Experiment Videos
Medtronic-Hall valve: thromboembolic complications
Insights
Thromboembolic complications occurred in 23.8% of patients with mitral valve prostheses and 24% with aortic prostheses. Aspirin significantly reduced complications in aortic valve replacement patients.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
Background:
- Mechanical heart valves, such as the Medtronic-Hall prosthesis, are used to replace damaged valves.
- Thromboembolic complications remain a significant concern following valve replacement surgery.
Purpose of the Study:
- To investigate the incidence of thromboembolic complications in patients with Medtronic-Hall prostheses.
- To identify risk factors associated with these complications in mitral and aortic positions.
- To evaluate the impact of aspirin on complication rates.
Main Methods:
- Retrospective study of 46 patients with Medtronic-Hall prostheses (21 mitral, 25 aortic).
- Analysis of pre-defined thromboembolic risk factors.
- Comparison of complication rates between valve positions and impact of aspirin therapy.
Main Results:
- Overall thromboembolic complication rates were 23.8% (mitral) and 24% (aortic).
- In mitral position, risk factors included prior thromboembolism, previous surgeries, atrial fibrillation, and postoperative heart failure/low output.
- In aortic position, only postoperative low output syndrome correlated with complications; aspirin reduced incidence from 26% to 16%.
Conclusions:
- Thromboembolic complication rates, while seemingly high, are influenced by patient clinical circumstances.
- Aspirin therapy demonstrates a significant benefit in reducing thromboembolic events in aortic position Medtronic-Hall prosthesis recipients.
Unlabelled:
We have studied the incidence of thromboembolic complications in 46 patients. Twenty-one patients had a Medtronic-Hall prosthesis implanted in the mitral position (group A) and 25 patients had the same prosthesis implanted in the aortic position (group B). Several factors were defined initially as "thromboembolic risk factors" and we have tried to establish a correlation between those factors and the actual thromboembolic complications. Group A: 21 patients presented 5 thromboembolic accidents (23.8%). Preeminent factors were: preoperative thromboembolic phenomena, previous heart operations, atrial fibrillation and the presence of congestive heart failure and/or low outpout syndrome in the postoperative period. Group B: 25 patients presented 6 thromboembolic accidents (24%). If we exclude the presence of low outpout syndrome in the postoperative period, there was no correlation between other risk factors and the incidence of thromboembolic complications. We must mention that the incidence of thromboembolic complications in this group diminished significantly (26% to 16%) when oral anticoagulation was continued with aspirin.
Commentary:
these figures of thromboembolic complications appear too high at first sight if we consider only their absolute value, but are justified when one bears in mind the clinical circumstances of the patients who suffered from thromboembolic complications.